Ali Tafreshi is CEO of Oku Digital Health, an AI-powered digital health company that connects eye insights to whole-body care. He also remains CEO of Topcon Healthcare and Chief Strategy Officer of Topcon Corp.'s Eyecare Business Division.

Ali spent about 10 years in glaucoma clinical research at the Hamilton Glaucoma Research Center in San Diego, working as a research associate, clinical trials manager and research coordinator. He then moved to industry at Heidelberg Engineering, rising to Global Head and VP of Product Management and Clinical Affairs.

Ali holds a Bachelor of Science in Biological Sciences from UC San Diego and has more than 20 years in eye care. He champions oculomics, the use of eye data to determine both eye and systemic health, under a strategy he calls Healthcare from the Eye.

Ali was named President and CEO of Topcon Healthcare in April 2024, after serving as its Chief Officer of Strategy, Innovation, and Clinical Development. He assembled Oku's founding leadership team, which includes executives with backgrounds at Microsoft, NVIDIA, Stanford and Genentech.

Oku launched globally in October 2026 across a connected network of more than 10,000 care locations. To date it has screened over 2.2 million patients outside of traditional eye care, surfacing more than 590,000 suspected pathology findings.